ARCHIVES

Clinical Trials Approved By NCI CTEP Last Month

This article is from The Cancer Letter archive.

Vol. 34 No. 3 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

Amgen, J&J Defend ESA Indications.

March 21, 2008

Mayo Clinic Cancer Center Wins NCI Support Grant Renewal

June 19, 2009

Sponsors Withdraw Indications for Iressa, Celebrex

February 11, 2011

Novartis Submits Gleevec Data To FDA Seeking Approval For Use In GI Tumors.

October 26, 2001

USC Scientists Says It’s Time Nobelists Recognize Value of Cancer Program

February 10, 1978

NCI Programs: BSA Approves Formation Of Two Grant Programs:

July 2, 1999